IRIS Accounts Production v25.1.4.42 10476221 director 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104762212024-03-31104762212025-03-31104762212024-04-012025-03-31104762212023-03-31104762212023-04-012024-03-31104762212024-03-3110476221ns15:EnglandWales2024-04-012025-03-3110476221ns14:PoundSterling2024-04-012025-03-3110476221ns10:Director12024-04-012025-03-3110476221ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3110476221ns10:SmallEntities2024-04-012025-03-3110476221ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3110476221ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3110476221ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3110476221ns10:FullAccounts2024-04-012025-03-3110476221ns10:OrdinaryShareClass12024-04-012025-03-3110476221ns10:OrdinaryShareClass22024-04-012025-03-3110476221ns10:CompanySecretary12024-04-012025-03-3110476221ns10:RegisteredOffice2024-04-012025-03-3110476221ns5:CurrentFinancialInstruments2025-03-3110476221ns5:CurrentFinancialInstruments2024-03-3110476221ns5:ShareCapital2025-03-3110476221ns5:ShareCapital2024-03-3110476221ns5:RetainedEarningsAccumulatedLosses2025-03-3110476221ns5:RetainedEarningsAccumulatedLosses2024-03-3110476221ns5:LeaseholdImprovements2024-04-012025-03-3110476221ns5:FurnitureFittings2024-04-012025-03-3110476221ns5:ComputerEquipment2024-04-012025-03-3110476221ns5:LeaseholdImprovements2024-03-3110476221ns5:PlantMachinery2024-03-3110476221ns5:FurnitureFittings2024-03-3110476221ns5:ComputerEquipment2024-03-3110476221ns5:PlantMachinery2024-04-012025-03-3110476221ns5:LeaseholdImprovements2025-03-3110476221ns5:PlantMachinery2025-03-3110476221ns5:FurnitureFittings2025-03-3110476221ns5:ComputerEquipment2025-03-3110476221ns5:LeaseholdImprovements2024-03-3110476221ns5:PlantMachinery2024-03-3110476221ns5:FurnitureFittings2024-03-3110476221ns5:ComputerEquipment2024-03-3110476221ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3110476221ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3110476221ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2025-03-3110476221ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-03-3110476221ns10:OrdinaryShareClass12025-03-3110476221ns10:OrdinaryShareClass22025-03-31
REGISTERED NUMBER: 10476221 (England and Wales)















Independent NeuroScience Services INSS
Limited

Unaudited Financial Statements for the Year Ended 31 March 2025






Independent NeuroScience Services INSS
Limited (Registered number: 10476221)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Independent NeuroScience Services INSS
Limited

Company Information
for the Year Ended 31 March 2025







DIRECTOR: Dr B Pichler





SECRETARY: Dr D E Pichler





REGISTERED OFFICE: The Briars
South Chailey
Lewes
East Sussex
BN8 4AN





REGISTERED NUMBER: 10476221 (England and Wales)





ACCOUNTANTS: Swindells LLP
Chartered Accountants
Atlantic House
8 Bell Lane
Bellbrook Industrial Estate
Uckfield
East Sussex
TN22 1QL

Independent NeuroScience Services INSS
Limited (Registered number: 10476221)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 31,703 28,166

CURRENT ASSETS
Stocks 83,663 108,332
Debtors 5 75,079 258,675
Cash at bank 530,846 185,605
689,588 552,612
CREDITORS: AMOUNTS FALLING DUE
WITHIN ONE YEAR

6

208,330

51,949
NET CURRENT ASSETS 481,258 500,663
TOTAL ASSETS LESS CURRENT
LIABILITIES

512,961

528,829

PROVISIONS FOR LIABILITIES 2,271 -
NET ASSETS 510,690 528,829

CAPITAL AND RESERVES
Called up share capital 7 200 200
Retained earnings 510,490 528,629
SHAREHOLDERS' FUNDS 510,690 528,829

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Independent NeuroScience Services INSS
Limited (Registered number: 10476221)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit & Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 7 October 2025 and were signed by:





Dr B Pichler - Director


Independent NeuroScience Services INSS
Limited (Registered number: 10476221)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Independent NeuroScience Services INSS Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents revenue, net of VAT, from commercial transactions under which the company supplies customers the goods and services that it is in business to provide and it is recognised when it obtains, through performance under contract, the right to consideration for those goods and services.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Garden office - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit & Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Independent NeuroScience Services INSS
Limited (Registered number: 10476221)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off to the profit and loss account in the year in which it is incurred unless its future recoverability can reasonably be assured, in which case it is carried forward as an intangible asset.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company contributes to the pension schemes of its employees. Contributions payable to these schemes are charged to the profit and loss account in the period to which they relate.

Leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 5 ) .

Independent NeuroScience Services INSS
Limited (Registered number: 10476221)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. TANGIBLE FIXED ASSETS
Fixtures
Garden Plant and and Computer
office machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 32,190 - 2,098 9,507 43,795
Additions - 9,762 4,098 441 14,301
Disposals - - - (732 ) (732 )
At 31 March 2025 32,190 9,762 6,196 9,216 57,364
DEPRECIATION
At 1 April 2024 8,048 - 1,792 5,789 15,629
Charge for year 6,036 2,441 1,099 988 10,564
Eliminated on disposal - - - (532 ) (532 )
At 31 March 2025 14,084 2,441 2,891 6,245 25,661
NET BOOK VALUE
At 31 March 2025 18,106 7,321 3,305 2,971 31,703
At 31 March 2024 24,142 - 306 3,718 28,166

5. DEBTORS
2025 2024
£    £   
Amounts falling due within one year:
Trade debtors 3,520 97,431
Other debtors 64,751 161,244
68,271 258,675

Amounts falling due after more than one year:
Other debtors 6,808 -

Aggregate amounts 75,079 258,675

Independent NeuroScience Services INSS
Limited (Registered number: 10476221)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 16,616 4,113
Taxation and social security 1,244 950
Other creditors 190,470 46,886
208,330 51,949

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary A £1 100 100
100 Ordinary B £1 100 100
200 200

8. OFF-BALANCE SHEET ARRANGEMENTS

Total commitments under a motor lease agreement amount to £24,422 (2024: £nil).

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

During the year, the company made advances to the director of £17,255 (2024: £35,719) and was repaid £17,268 (2024: £35,546). At the balance sheet date the company owed the director £1,152 (2024: £1,139). The loan is interest free, unsecured and repayable on demand.

10. RELATED PARTY DISCLOSURES

During the year, total dividends of £10,000 (2024 - £2,000) were paid to the director .